Rank;Global Rank;Institution;Country;Sector
1;269;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies;
2;317;Hoffmann-La Roche, GmbH., Germany;DEU;Companies;
3;318;Philips Research, Eindhoven;NLD;Companies;
4;339;Roche Products Ltd, United Kingdom;GBR;Companies;
5;357;AstraZeneca, United Kingdom;GBR;Companies;
6;430;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies;
7;479;Novo Nordisk A/S;DNK;Companies;
8;524;Sanofi, France;FRA;Companies;
9;558;Janssen Research & Development, LLC;BEL;Companies;
10;588;AstraZeneca, Sweden;SWE;Companies;
11;621;Merck KGaA, Germany;DEU;Companies;
12;633;Danone Nederland BV;NLD;Companies;
13;717;Siemens AG, Germany;DEU;Companies;
14;734;Bayer AG, Germany;DEU;Companies;
15;830;Nestle Switzerland;CHE;Companies;
16;868;Pfizer Inc, Spain;ESP;Companies;
17;876;VTT Technical Research Centre of Finland;FIN;Companies;
18;878;Boehringer Ingelheim GmbH Germany;DEU;Companies;
19;920;Siemens Healthineers, Germany;DEU;Companies;
20;944;IMEC International;BEL;Companies;
21;949;Novartis, Switzerland;CHE;Companies;
22;991;UCB Pharma SA, Belgium;BEL;Companies;
23;1004;GlaxoSmithKline, United Kingdom;GBR;Companies;
24;1040;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies;
25;1108;GlaxoSmithKline, Belgium;BEL;Companies;
26;1557;BASF, Germany;DEU;Companies;
27;1731;Bosch, Germany;DEU;Companies;
28;1983;Pfizer Inc, United Kingdom;GBR;Companies;
29;2473;SINTEF Group *;NOR;Companies;
30;4802;Grupo Jose de Mello *;PRT;Companies;
31;5074;IQVIA, Germany;DEU;Companies;